As of 2025-10-22, the Relative Valuation of Atossa Therapeutics Inc (ATOS) is (0.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.96 USD, the upside of Atossa Therapeutics Inc based on Relative Valuation is -106.9%.
The range of the Relative Valuation is (0.05) - (0.08) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 0.2x - 0.4x | 0.3x |
| Fair Price | (0.05) - (0.08) | (0.07) |
| Upside | -105.5% - -108.3% | -106.9% |
| Date | P/E |